<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-02T11:36:38+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020港股市场火热，生物药企扎堆上市丨医麦新观察</title>
    <updated>2021-01-02T07:29:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/S0NcQ8fAqGKzoaj8Mp5JGQ</id>
    <link href="https://mp.weixin.qq.com/s/S0NcQ8fAqGKzoaj8Mp5JGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向CD45抗体公布最新数据，联合疗法可发挥更好的治疗作用丨医麦猛爆料</title>
    <updated>2021-01-02T07:29:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/rJNpcfVRmKBm9H04Q4REUw</id>
    <link href="https://mp.weixin.qq.com/s/rJNpcfVRmKBm9H04Q4REUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020仁医专访集锦丨仁心仁术守护生命，带给患者希望之光~</title>
    <updated>2021-01-02T07:29:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/-9Aeykb6XIP3IwNiEvFI7w</id>
    <link href="https://mp.weixin.qq.com/s/-9Aeykb6XIP3IwNiEvFI7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曾宪放博士加盟鼎康生物，出任鼎康生物首席执行官丨医麦猛爆料</title>
    <updated>2020-12-31T21:18:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/iQms0w-Sa5Yoowk32w5DTw</id>
    <link href="https://mp.weixin.qq.com/s/iQms0w-Sa5Yoowk32w5DTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>元旦特辑丨迎接2021年的第一缕阳光，基因和细胞治疗监管政策全收集</title>
    <updated>2020-12-31T21:18:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/SGjih3-NYdvTwI3kwdWEMQ</id>
    <link href="https://mp.weixin.qq.com/s/SGjih3-NYdvTwI3kwdWEMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年度聚汇：医药行业最受用户关注的热点（上）丨医麦精品汇</title>
    <updated>2020-12-31T21:18:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/s2ylBWLMn6e7Fnn6YGhtCw</id>
    <link href="https://mp.weixin.qq.com/s/s2ylBWLMn6e7Fnn6YGhtCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年度聚汇：医药行业最受用户关注的热点（下）丨医麦精品汇</title>
    <updated>2020-12-31T21:18:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/1DutiFAV1y99kqG1PqDU1A</id>
    <link href="https://mp.weixin.qq.com/s/1DutiFAV1y99kqG1PqDU1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>可循环CAR (Recyclable CAR)——上科大将CAR-T疗法新突破的技术专利独家许可给恒润达生</title>
    <updated>2020-12-30T23:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/l_fVkRBy9QUnZogXJrp51g</id>
    <link href="https://mp.weixin.qq.com/s/l_fVkRBy9QUnZogXJrp51g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨冲击科创板，2020年生物医药上新企业</title>
    <updated>2020-12-30T23:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/H3IY_MkAyox0B_R_35Mr1A</id>
    <link href="https://mp.weixin.qq.com/s/H3IY_MkAyox0B_R_35Mr1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DC疫苗又获一笔高额融资，推进临床研究以预防新冠和治疗肿瘤丨医麦猛爆料</title>
    <updated>2020-12-30T23:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/7OYrnwFrEk6HRBsInRH_mA</id>
    <link href="https://mp.weixin.qq.com/s/7OYrnwFrEk6HRBsInRH_mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>获得逾20亿美元的资金支持，这款新冠疫苗启动关键Ⅲ期研究丨医麦猛爆料</title>
    <updated>2020-12-30T23:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/7dAZouUvR_TDVlT05hy4Zw</id>
    <link href="https://mp.weixin.qq.com/s/7dAZouUvR_TDVlT05hy4Zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议邀请函】核分子影像及PET在抗体药物组织分布研究中的应用专题研讨会</title>
    <updated>2020-12-30T23:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/Q4e9ZTEX3fYcpayTgAJ4kg</id>
    <link href="https://mp.weixin.qq.com/s/Q4e9ZTEX3fYcpayTgAJ4kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年末复盘：2020年国内基因治疗领域的融资与交易丨医麦新观察</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/2C20FGgJB5MR16eF-iNRaw</id>
    <link href="https://mp.weixin.qq.com/s/2C20FGgJB5MR16eF-iNRaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>告别昂贵的单细胞测序， 挖掘公共数据库的单细胞测序数据， 不需做实验就能发表文章（1.16-17  网络精讲班）</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/8IyuLTN0_5xpUEGxP6ZbjA</id>
    <link href="https://mp.weixin.qq.com/s/8IyuLTN0_5xpUEGxP6ZbjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>异体CD7 CAR-T 7天达到缓解，12岁肿瘤患儿重获新生丨医麦猛爆料</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/t5nLlDClaj5zvZPQ7m9_Xw</id>
    <link href="https://mp.weixin.qq.com/s/t5nLlDClaj5zvZPQ7m9_Xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资首发丨正序生物获万物、联新、红杉、泰福天使轮投资—开辟具有自主知识产权的碱基编辑疗法新赛道</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/6xByZpWf7HwrHctZ3ulIgg</id>
    <link href="https://mp.weixin.qq.com/s/6xByZpWf7HwrHctZ3ulIgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Claudin 18.2/PD-L1双抗新药临床试验申请获得CDE受理丨医麦猛爆料</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/u8mdnOMPFZlLHeu22A1vwg</id>
    <link href="https://mp.weixin.qq.com/s/u8mdnOMPFZlLHeu22A1vwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30亿美元布局基因治疗，日本制药巨头安斯泰来罕见病管线重见曙光丨医麦新观察</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/nqxODgmgVoM7fhpJnn0FHg</id>
    <link href="https://mp.weixin.qq.com/s/nqxODgmgVoM7fhpJnn0FHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仁医界专访丨陈波斌教授：中枢神经系统淋巴瘤诊疗属实不易，多学科合力攻坚开辟新天地</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/IP9e-jZcJJlDOmvdBC6zaw</id>
    <link href="https://mp.weixin.qq.com/s/IP9e-jZcJJlDOmvdBC6zaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体依然为王，那些热门的赛道现在入场还来得及吗？丨医麦新观察</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/bDJxanW6OZS4xk8Hnv9cFw</id>
    <link href="https://mp.weixin.qq.com/s/bDJxanW6OZS4xk8Hnv9cFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>